SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Category: Research and Developments

    Smoking and Wet AMD Treatment

    Posted on October 30, 2020January 3, 2021 by Dan Roberts
  • October 30, 2020

    Smoking and Wet AMD Treatment

    It has long been known that cigarette smoking reduces levels of plasma antioxidant, which protects retinal cells. It is also suspected as a contributor to cataract formation, restriction of night vision, and amblyopia (“lazy eye”). As reported in the September 2020 issue of the journal, Retina, a research team has confirmed the effect of smoking […]

      Also posted in
    • Latest News
    • Research and Developments
  • Levodopa may improve vision in patients with Wet AMD

    Posted on September 15, 2020September 15, 2020 by Dan Roberts
  • September 15, 2020

    Levodopa may improve vision in patients with Wet AMD

    Investigators have determined that treating patients with the early wet form of age-related macular degeneration (AMD) with levodopa, stabilized and improved their vision. Levodopa is a safe and readily available drug commonly used to treat Parkinson’s disease, The drug reduced the number of treatments necessary to maintain vision, and as such, will potentially reduce the […]

      Also posted in
    • Latest News
    • Research and Developments
  • Zimura® Shows Significant Suppression of Geographic Atrophy

    Posted on September 8, 2020 by Dan Roberts
  • September 8, 2020

    Zimura® Shows Significant Suppression of Geographic Atrophy

    IVERIC bio, Inc. has announced positive Phase 3 results from its GATHER1 clinical trial with Zimura® (avacincaptad pegol). As published in the September issue of Ophthalmology®, Zimura® met its pre-specified primary efficacy endpoint at 12 months and reached statistical significance in GATHER1, an international, multicenter, randomized, double masked, sham controlled clinical trial.  Zimura® inhibits complement […]

      Also posted in
    • Research and Developments
  • AAO Cautions About Red Light Therapy

    Posted on September 7, 2020September 7, 2020 by Dan Roberts
  • September 7, 2020

    AAO Cautions About Red Light Therapy

    An article published here in August 2020 announced that positive results were obtained from a study of photobiomodulation (PBM)–also known as “red light therapy”– as a treatment for eye diseases such as AMD, retinopathy of prematurity, and diabetic macular edema. The American Academy of Ophthalmology has simultaneously posted cautionary remarks about recent PBM research. In […]

      Also posted in
    • Research and Developments
  • Light Therapy Showing Success As Retinal Treatment

    Posted on August 17, 2020August 17, 2020 by Dan Roberts
  • August 17, 2020

    Light Therapy Showing Success As Retinal Treatment

    According to an article in the August 6, 2020 edition of Ophthalmology Times, a procedure called photobiomodulation (PBM) has had recent success in treating eye diseases such as AMD, retinopathy of prematurity, and diabetic macular edema. PBM, or low-level light therapy, is the application of monochromatic light to a part of the body with the […]

      Also posted in
    • Latest News
    • Research and Developments
    • Therapies, Treatments, and Procedures
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 51
  • Next Page »
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.